当前位置:首页 - 行情中心 - 健帆生物(300529) - 财务分析 - 现金流量表

健帆生物

(300529)

  

流通市值:136.33亿  总市值:211.18亿
流通股本:5.21亿   总股本:8.08亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金878,543,970.512,367,689,535.321,775,021,362.971,216,659,732.55
收到的税费返还428,149.532,404,235.012,386,704.172,172,142.07
收到其他与经营活动有关的现金23,704,164.98153,398,747.21111,126,926.367,034,774.59
经营活动现金流入的平衡项目0000
经营活动现金流入小计902,676,285.022,523,492,517.541,888,534,993.441,285,866,649.21
购买商品、接受劳务支付的现金71,265,649.66318,419,892.98308,780,072.47168,313,968.23
支付给职工以及为职工支付的现金114,030,976.47570,809,309.7437,413,789.12313,613,874.78
支付的各项税费88,154,176.13257,938,620.5186,492,985.3121,400,495.39
支付其他与经营活动有关的现金122,130,236.33459,580,827.47365,805,720.39245,839,824
经营活动现金流出的平衡项目0000
经营活动现金流出小计395,581,038.591,606,748,650.651,298,492,567.28849,168,162.4
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额507,095,246.43916,743,866.89590,042,426.16436,698,486.81
二、投资活动产生的现金流量:
收回投资收到的现金422,000,000---
取得投资收益收到的现金2,528,325.71---
处置固定资产、无形资产和其他长期资产收回的现金净额69,025.3512,604,014.512,020,714.59,276,922
投资活动现金流入的平衡项目0000
投资活动现金流入小计424,597,351.0612,604,014.512,020,714.59,276,922
购建固定资产、无形资产和其他长期资产支付的现金95,865,172.16247,253,333.78100,962,321.9872,542,074.03
投资支付的现金1,168,000,00015,000,000--
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,263,865,172.16262,253,333.78100,962,321.9872,542,074.03
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-839,267,821.1-249,649,319.28-88,941,607.48-63,265,152.03
三、筹资活动产生的现金流量:
吸收投资收到的现金-128,108.6128,108.6128,108.6
取得借款收到的现金251,826,834.7762,916,625.18736,779,555.51446,374,555.51
收到其他与筹资活动有关的现金-130,168,752.5127,505,141.3129,657,448.76
筹资活动现金流入平衡项目0000
筹资活动现金流入小计251,826,834.7893,213,486.28864,412,805.41576,160,112.87
偿还债务支付的现金126,504,271.11344,496,425.32261,588,575.322,000,000
分配股利、利润或偿付利息支付的现金5,531,093.48561,785,556.62557,936,395.22550,985,624.71
支付其他与筹资活动有关的现金213,000,000438,842,794.71383,868,930.46257,908,304.45
筹资活动现金流出平衡项目0000
筹资活动现金流出小计345,035,364.591,345,124,776.651,203,393,901810,893,929.16
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-93,208,529.89-451,911,290.37-338,981,095.59-234,733,816.29
四、汇率变动对现金及现金等价物的影响-48,879.2911,394.79-18,550.06-29,132.91
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-425,429,983.85215,194,652.03162,101,173.03138,670,385.58
加:期初现金及现金等价物余额2,741,543,287.882,526,348,635.852,526,348,635.852,526,348,635.85
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额2,316,113,304.032,741,543,287.882,688,449,808.882,665,019,021.43
补充资料:
净利润-425,723,151.05-275,203,101.22
资产减值准备-19,953,076.37--3,970,098.57
固定资产和投资性房地产折旧-86,416,077.51-42,097,720.13
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-86,416,077.51-42,097,720.13
无形资产摊销-4,025,970.22-1,950,829.22
长期待摊费用摊销-18,190,024.43-5,172,866.43
处置固定资产、无形资产和其他长期资产的损失--6,719,584.13--6,056,875.34
固定资产报废损失-321,084.73-224,541.43
财务费用-54,333,084.61-25,227,139.34
递延所得税--1,014,011.8-15,629,055.9
其中:递延所得税资产减少-1,624,245.14-398,015.85
递延所得税负债增加--2,638,256.94-15,231,040.05
存货的减少--37,299,221.58--13,521,947.8
经营性应收项目的减少-277,224,641.45-92,890,796.58
经营性应付项目的增加-52,142,254.97--8,184,979.67
其他-19,096,732.27-8,357,124.99
现金的期末余额-2,741,543,287.88-2,665,019,021.43
减:现金的期初余额-2,526,348,635.85-2,526,348,635.85
公告日期2024-04-262024-04-262023-10-282023-08-19
审计意见(境内)标准无保留意见
TOP↑